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Pompeo et al General Thoracic Surgery3-year exercise capacity, 5-year relief of dyspnea, and better
5-year survival than medically treated patients.
In the current series entailing all patients with upper-lobe
emphysema, estimated 3-year survival was greater than
80% in both study groups. So far, endoscopic procedures
proposed as an alternative to LVRS did not demonstrate
comparable efficacy.6 Thus, we confide that results of our
trial will provide further scientific data directed at accentu-
ating the positive16 role of surgery in the optimal manage-
ment of patients with emphysema.G
T
SLimitations
Limitations of this study include the small cohort with an
intergroup difference in baseline total lung capacity and the
mixed combination of 2 types of anesthesia and 2 types of
surgical methods that negated the possibility to weigh the
role of each single component in determining the final out-
comes. To attenuate these concerns, we have completed
a small, preliminary study comparing nonresectional LVRS
performed by awake or nonawake anesthesia.8 However,
we considered it unethical to perform a randomized study
comparing the results of an unconventional LVRS method
(eg, our nonresectionalLVRS technique carried out by awake
or nonawake anesthesia) because this surgical technique is
currently used by our center only, and so far there were no
other prospectively collected data confirming its reliability
when comparedwith resectional LVRS,which is still consid-
ered the gold standard by most thoracic surgeons.
We acknowledge that both the design of the trial and our
strategy entailing an intentional, initial unilateral operation
may have led to an apparent overestimation of some out-
come data because of exclusion of patients undergoing con-
tralateral treatment during time. However, we were
interested in comparing the degree of improvements in ho-
mogeneous cohorts including only patients treated in unilat-
eral fashion. Nonetheless, we have considered the need of
contralateral treatment a negative event as death, and
assessed this secondary outcome measure by the Kaplan–
Meier method, thus providing useful comparative data on
long-term outcome of all patients.CONCLUSIONS
In this randomized study, awake nonresectional LVRS
was associated with a greater proportion of early discharges
than the control group, while offering equivalent and long-
lasting clinical improvements in FEV1 and other outcome
measures. In addition, no difference was observed between
study groups in survival and need of contralateral treatment
for up to 36 months.References
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Dr BryanMeyers (St Louis, Mo). The authors have provided us
with a noteworthy trial comparing 2 alternative strategies for
LVRS in patients with advanced emphysema. The degree of im-
pairment in these patients is consistent with that seen in other re-
ports, and the amount of FEV1 improvement of approximately
37% at 6 months is certainly comparable or even better than often
seen with unilateral volume reduction surgery. So the clinical care
is to be commended. The study is prospective and randomized,
which is certainly what caught the attention of the program com-
mittee. I commend the authors on the ability to initiate and com-
plete a prospective randomized study, particularly when the 2
arms of therapy are as disparate as awake versus nonawake anes-
thetic. That’s quite a challenge, and I commend you. I do have
a few concerns that you have alreadymentioned in your limitations
that I want to underscore. The one problem I had was that the de-
sign changes 2 things as youmove from one group to the other. You
have awake and nonresection compared with nonawake and resec-
tion, and that leaves us in some doubt as we interpret the results of
the study as to which factors might contribute to the overall end re-
sult. Why did you do that? Why not alter one thing at a time andardiovascular Surgery c Volume 143, Number 1 53
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Sthen give us some insight as to how each factor might affect the
outcome?
Dr Pompeo. This is one limitation of the study that we had con-
sidered. For this reason, we had performed a small prospective
nonrandomized study comparing awake nonresectional lung vol-
ume reduction with nonawake nonresectional lung volume reduc-
tion. We recently published it in the European Journal of
Cardiothoracic Surgery, and we specifically wanted to publish it
before the presentation of this randomized study for this reason,
because we were interested in seeing if the nonresectional method
per se is sufficient to say that it can improve early results. What we
have seen is that the results were not as good as with the double
association of the nonresectional method and awake anesthesia.
This might be one answer.
Dr Meyers. Another point I would make is that you analyzed
this per protocol, that is, you chose not to use an intention-to-treat
analysis. You excluded 2 patients who could not tolerate the awake
procedure and 1 patient who was converted from the VATS ap-
proach to an open approach, and when we evaluate treatment strat-
egies, we have to compare all patients who were exposed to that
strategy and not just patients who were successfully treated with
that strategy. So I would just point that out. The final point is
that your sample size of 30 in each arm is small, although nowa-
days there aren’t a whole lot of patients needing lung volume re-
duction, and it might be small by necessity. But you justified it
by picking a primary outcome measure that I would argue is not
a clinically important factor. The fraction of patients who are dis-
charged at or before 6 days is not what I think of as the main thing
that I want to evaluate when I compare 2 strategies for LVRS. So
I’m not sure that the sample size was really sufficient to give us the
full insight into these 2 therapies.
Dr Pompeo. This is probably true. We had to choose the out-
come measure as a compromise to reach a sufficient power to per-
form the study. Obviously a larger sample size might have been
better, but it’s difficult when doing a single-center study to have
such a large quantity of patients to randomize.
Dr Meyers. I would summarize by saying this was excellent
clinical care. Both patients in both arms got a great boostwith a uni-
lateral LVRS, although my own bias would be to offer a bilateral
operation, and the conduct of the trial could have been better, but
itwas thought provoking and novel therapy on the intervention arm.
Dr Pompeo. Thank you.
Dr Scott Swanson (Boston, Mass). I enjoyed that article and am
interested in that technique. We actually published on that in the
mid-1990s. Could you give us some tips on how you actually do
it, particularly on an awake patient? Is there anything we can learn
from you about the technical part of this operation?
Dr Pompeo. There are several small tricks you can apply to op-
erate on these patients. What we have seen during time with this
kind of operation is that if the operation becomes too long, permis-
sive hypercapnia can become a problem for the patient. We have
resolved this problem in the last years by inserting a chest tube
at the beginning of the operation. In this way we can temporarily
close the trocars with fingers or gauzes and allow reexpansion of
the lung during the operation, and this has consistently reduced
the PaCO2, during the procedure. Another thing is to discuss with
the patient during the operation that difficulty in breathing can54 The Journal of Thoracic and Cardiovascular Surgebe due to the surgical pneumothorax, because the patient can
feel difficulty even though the oxygenation remains at a satisfac-
tory level. With experience you will find that the operation is
quick, simple, and safe, and I think for these patients, avoiding
general anesthesia is a big advance.
Dr J. Shrager. Scott, is this technique exactly what you de-
scribed when you reported it? I seem to recall that you do some
sort of twisting of the parenchyma that is a bit different than this?
Dr Swanson. I’m not quite sure. Yes, wewere folding along and
then stapling.
Dr Pompeo. But there is a difference between the techniques.
Dr Swanson proposed a folding technique, repeatedly folding on
the lung surface, whereas we perform a single introflexing plica-
tion.We push the lung down inside the underlying tissue and suture
it above, along a single ideal line, as with the resectional technique.
Dr Shrager. Sort of like plicating a diaphragm. Is that what
you’re trying to describe?
Dr Pompeo. Yes, something like that.
Dr Swanson. I have just one follow-up question. Were you able
to dealwith adhesions through this technique, orwas that a problem?
Dr Pompeo. Sorry?
Dr Swanson.Did you run into any adhesions in the chest during
the awake cases, and if so, can you handle adhesions to the chest
wall with this technique?
Dr Pompeo. Well, regarding adhesions, it’s not really a prob-
lem. We normally use an EndoPaddle to push on the lung and
see the apical parts of the lung better to cut the adhesions. It
may require some more time than with a resectional technique,
but it’s quite simple as well.
Dr Walter Weder (Zurich, Switzerland). Congratulations on
your work. I have 2 questions. Why did you offer all these patients
a unilateral and not a bilateral volume reduction?
Dr Pompeo. We actually offered a staged bilateral procedure.
What we do is initially perform a unilateral procedure. As you
probably know, we are convinced that a staged bilateral procedure
is better than a 1-stage bilateral procedure. Some studies have
demonstrated that after a 1-stage bilateral procedure, the decay
in FEV1 is approximately 250 mL/year, whereas after a unilateral
procedure, the decay is approximately 107 mL/year, and we be-
lieve this is a good reason to do a staged procedure if the patient
can improve significantly with a unilateral lung volume reduction.
DrWeder. In your Abstract you stated that the improvement of
FEV1 lasted for 3 years, and in your presentation you said it was
statistically improved for 2 years. You excluded all patients who
had failures and needed a second operation. Do you think it is cor-
rect to exclude the worst cases for evaluating the long-term effect?
Dr Pompeo. This is an important question. Our aim was not to
demonstrate that lung volume reduction is capable of improving
pulmonary function. We know that this is possible, and I think
there are already enough data to demonstrate this. What we were
interested in was to compare the results between the awake and
nonawake procedures. I know that in this way, by excluding pa-
tients who were operated contralaterally, we have created a bias,
but the bias is unavoidable, because otherwise we had to consider
all the patients, and we had some patients operated unilaterally and
some bilaterally. We would prefer to show the results of the bilat-
eral procedures later.ry c January 2012
